*** Cbp--
  *** Cbp[Ab] boundto(IL2Ra-gene)[ChIP] is increased irt IL12 (times)
    *** cells: mSpCs in BMS "pretreated with anti-Cd3 for 72 hr"
    *** times: 0 2++ 4++ 6+ 24 hr
    *** source: 14660657-Fig-4
*** CcL3--
  *** CcL3-gene mRNA[RPA] is increased irt IL12 (4 hr)
    *** cells: hPHAblasts in BMS
    *** source: 10358173-Fig-1a
*** CcL4--
  *** CcL4-gene mRNA[RPA] is increased irt IL12 (4 hr)
    *** cells: hPHAblasts in BMS
    *** source: 10358173-Fig-1a
*** Cldn3--
  *** Cldn3-gene mRNA[RPA] is increased irt IL12 (4 hr)
    *** cells: hPHAblasts in BMS
    *** source: 10358173-Fig-1a
*** Dad1--
  *** Dad1-gene mRNA[RPA] is detectable-but unchanged irt IL12 (4 hr)
    *** cells: hPHAblasts in BMS
    *** source: 10358173-Fig-1a
*** Erk2--
  *** Erk2[Ab]IP IVKA(MBP)[32P-ATP] is increased irt IL2 (15 min)
    *** cells: hPBTCs in BMS
    *** source: 10961885-Fig-2b
  *** Erk2[Ab]IP IVKA(MBP)[32P-ATP] is unchanged irt IL12 (15 min)
    *** cells: hPBTCs in BMS
    *** source: 10961885-Fig-2b
  *** Erk2[Ab]IP Yphos[pYAb] is increased irt IL2 (15 min)
    *** cells: hPBTCs in BMS
    *** source: 10961885-Fig-2c
  *** Erk2[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: hPBTCs in BMS
    *** source: 10961885-Fig-2c
  *** xErk2[tAb]IP IVKA(MBP)[32P-ATP] is unchanged irt IL12 (times)
    *** cells: NIH3T3<xIL12Rb1><xIL12Rb1><xErk2> in BMS
    *** times: 0 30 45 min
    *** source: 10961885-Fig-3a
*** Erks--
  *** Erks[phosAb] phos(TEY)[phosAb] is unchanged irt IL12 (5 min)
    *** cells: hPBTCs in BMLS
    *** source: 10849428-Fig-3a
  *** Erks[phosAb] phos(TEY)[phosAb] is unchanged irt IL12 (15 min)
    *** cells: hPBTCs<Itgb2~neg><Cd8~pos><Cd56~neg><Cd4~neg><Cd20~neg> in BMS
    *** unaffected by: IL2 [cotreatment]
    *** source: 10201984-Fig-2a
  *** Erks[phosAb] phos(TEY)[phosAb] is unchanged irt IL12 (15 min)
    *** cells: hPBTCs<Itgb2~pos><Cd8~pos><Cd56~neg><Cd4~neg><Cd20~neg> in BMS
    *** unaffected by: IL2 [cotreatment]
    *** source: 10201984-Fig-2a
  *** Erks[phosAb] phos(TEY)[phosAb] is unchanged irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 2+ 5+ 10+ 20+ 30+ min
    *** source: 16763563-Fig-3d
*** FasR--
  *** FasR-gene promo-reporter[Luc] is increased irt IL12 (times)
    *** cells: LM7 in BMS
    *** times: 0 2+ 4++ 8+ 24 hr
    *** source: 16380506-Fig-4
  *** FasR-gene promo-reporter[Luc] is increased irt IL12 (times)
    *** cells: TC71 in BMS
    *** times: 0 2+ 4++ 8+ 24 hr
    *** source: 16380506-Fig-4
*** Gab2--
  *** Gab2[Ab]IP Yphos[pYAb] is unchanged irt IL12 (5 min)
    *** cells: hPBTCs in BMLS
    *** source: 10849428-Fig-1a
  *** Gab2[Ab]IP Yphos[pYAb] is unchanged irt IL12 (5 min)
    *** cells: NK33 in BMLS
    *** source: 10849428-Fig-1c
  *** Gbp?-gene mRNA[RPA] is detectable-but unchanged irt IL12 (4 hr)
    *** cells: hPHAblasts in BMS
    *** source: 10358173-Fig-1a
*** Gpb--
*** Grb2--
  *** Grb2[Ab] copptby[WB] Shc1[Ab] is increased irt IL2 (15 min)
    *** cells: hPBTCs in BMS
    *** source: 10961885-Fig-2b
  *** Grb2[Ab] copptby[WB] Shc1[Ab] is unchanged irt IL12 (15 min)
    *** cells: hPBTCs in BMS
    *** source: 10961885-Fig-2b
*** Gzmb--
*** Hlx--
  *** Hlx-gene mRNA[RTPCR] is decreased irt IL12 (times)
    *** cells: mSpCD4TCs in BMS "pretreated with anti-Cd3 + anti-Cd28 + anti-IL4 (48 hr)"
    *** times: 0+ 24 48 72+ 96+ 120++ 144++ hr
    *** source: 19409816-Fig-5e
*** Ifit2--
  *** Ifit2-gene mRNA[RPA] is unchanged irt IL12 (4 hr)
    *** cells: hPHAblasts in BMS
    *** source: 10358173-Fig-1a
*** Ifng--
  *** Ifng[Ab] secretion[ELISA] is increased irt IL12 (60 hr)
    *** cells: hPHAblasts in BMS "cultured with anti-Cd3 + anti-Cd28"
    *** unaffected by: anti-IL12Rb1 [cotreatment]
    *** inhibited by: anti-IL12 [cotreatment]
    *** partially inhibited by: anti-IL12a [cotreatment]
    *** source: 11114383-Fig-6a
  *** Ifng[Ab] secretion[ELISA] is increased irt IL12 (times)
    *** cells: hPBMCs in BMS "Cd45ra-pos cultured with anti-Cd3 + anti-Cd28"
    *** times: 3+ 6++ days
    *** source: 11114383-Fig-6c
  *** Ifng[Ab] secretion[ELISA] is increased irt IL12 (times)
    *** cells: hPBMCs in BMS "Cd45ro-pos cultured with anti-Cd3 + anti-Cd28"
    *** times: 3+ 6++ days
    *** source: 11114383-Fig-6c
  *** Ifng[Ab] secretion[ELISA] is increased irt IL12 (36 hr)
    *** cells: mLCs in BMS "activated with anti-Cd3 for 48 hr"
    *** unaffected by: SB202474 [addition]
    *** partially inhibited by: SB203580 [addition]
    *** partially inhibited by: SB202190 [addition]
    *** source: 10903740-Fig-2b
*** IL1R1--
  *** IL1R1-gene mRNA[RPA] is increased irt IL12 (4 hr)
    *** cells: hPHAblasts in BMS
    *** source: 10358173-Fig-1a
  *** IL1R1-gene mRNA[RTPCR] is detectable-but unchanged irt IL12 (72 hr)
    *** cells: mSpBCs in BMS
    *** source: 9759857-Fig-3b
  *** IL1R1-gene mRNA[RTPCR] is detectable-but unchanged irt IL12 (72 hr)
    *** cells: mSpTCs in BMS
    *** source: 9759857-Fig-3b
*** IL1R2--
  *** IL1R2-gene mRNA[RTPCR] is detectable-but unchanged irt IL12 (72 hr)
    *** cells: mSpBCs in BMS
    *** source: 9759857-Fig-3b
  *** IL1R2-gene mRNA[RTPCR] is detectable-but unchanged irt IL12 (72 hr)
    *** cells: mSpTCs in BMS
    *** source: 9759857-Fig-3b
*** IL1Rap--
  *** IL1Rap-gene mRNA[RTPCR] is detectable-but unchanged irt IL12 (72 hr)
    *** cells: mSpBCs in BMS
    *** source: 9759857-Fig-3b
  *** IL1Rap-gene mRNA[RTPCR] is detectable-but unchanged irt IL12 (72 hr)
    *** cells: mSpTCs in BMS
    *** source: 9759857-Fig-3b
*** IL2Ra--
*** IL12Rb1--
  *** IL12Rb1-gene mRNA[Northern] is detectable-but unchanged irt IL12 (4 hr)
    *** cells: mSpCs in BMS "activated with anti-Cd3 for 48 hr"
    *** comment: cells from Stat4-null mice express less IL12Rb1-gene mRNA
    *** source: 11120802-Fig-1a
  *** IL12Rb1-gene mRNA[RTPCR] is increased irt IL12 (72 hr)
    *** cells: mSpBCs in BMS
    *** source: 9759857-Fig-1e
  *** IL12Rb1-gene mRNA[RTPCR] is increased irt IL12 (72 hr)
    *** cells: mSpTCs in BMS
    *** source: 9759857-Fig-1e
*** IL12Rb2--
  *** IL12Rb2-gene mRNA[Northern] is detectable-but unchanged irt IL12 (4 hr)
    *** cells: mSpCs in BMS "activated with anti-Cd3 for 48 hr"
    *** comment: cells from Stat4-null mice express less IL12Rb2-gene mRNA
    *** source: 11120802-Fig-1a
  *** IL12Rb2-gene mRNA[Northern] is increased irt IL12 (3 hr)
    *** cells: hNKCs in BMS "resting"
    *** source: 10925275-Fig-3
  *** IL12Rb2-gene mRNA[RTPCR] is increased irt IL12 (times)
    *** cells: mSpCD4TCs in BMS "pretreated with anti-Cd3 + anti-Cd28 + anti-IL4 (48 hr)"
    *** times: 0 1 2+ 3++ 4++ 5+++ days
    *** comment: addition of CsA on day 1 causes a faster increase
    *** comment: addition of CsA on day 1 causes a decrease at day 5
    *** source: 19409816-Fig-4e
  *** IL12Rb2-gene mRNA[RTPCR] is increased irt IL12 (times)
    *** cells: mSpCD4TCs in BMS "pretreated with anti-Cd3 + anti-Cd28 + anti-IL4 (48 hr)"
    *** times: 0 1+ 2++ 3+++ 4+++ 5++++ days
    *** partially reqs: IfngR1 [KO]
    *** source: 19409816-Fig-4b
  *** IL12Rb2-gene mRNA[RTPCR] is increased irt IL12 (72 hr)
    *** cells: mSpBCs in BMS
    *** source: 9759857-Fig-1e
  *** IL12Rb2-gene mRNA[RTPCR] is increased irt IL12 (72 hr)
    *** cells: mSpTCs in BMS
    *** source: 9759857-Fig-1e
*** IL18--
*** IL18R1--
*** IL18Rap--
*** Irak1--
  *** Irak1-gene mRNA[Northern] is detectable-but unchanged irt IL12 (4 hr)
    *** cells: mSpCs in BMS "activated with anti-Cd3 for 48 hr"
    *** source: 11120802-Fig-4a
*** Irf1--
*** Irs1--
  *** Irs1[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: hNKCs in BMLS
    *** source: 7499365-Fig-1c
  *** Irs1[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: hPHAblasts in BMLS
    *** source: 7499365-Fig-1a
*** Isg15--
  *** Isg15-gene mRNA[RPA] is unchanged irt IL12 (4 hr)
    *** cells: hPHAblasts in BMS
    *** source: 10358173-Fig-1a
  *** Isg15-gene mRNA[RPA] is unchanged irt IL12 (4 hr)
    *** cells: NK33 in BMS
    *** source: 10358173-Fig-3a
  *** Isg15-gene mRNA[RPA] is unchanged irt IL12 (4 hr)
    *** cells: NK33 in BMS "pretreated with CHX"
    *** source: 10358173-Fig-3b
*** Jak1--
  *** Jak1[Ab] Yphos[pYAb-ppt] is unchanged irt IL12 (15 min)
    *** cells: hPHAblasts in BMS
    *** source: 7528775-Fig-3b
  *** Jak1[Ab]IP Yphos[pYAb] is increased irt IL12 (15 min)
    *** cells: hPHAblasts in BMS
    *** source: 7568001-Fig-1b
*** Jak2--
*** Jak3--
  *** Jak3[Ab] Yphos[pYAb-ppt] is unchanged irt IL12 (15 min)
    *** cells: hPHAblasts in BMS
    *** source: 7528775-Fig-3a
  *** Jak3[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: hPHAblasts in BMS
    *** source: 7568001-Fig-1a
  *** Jak3[Ab]IP Yphos[pYAb] is unchanged irt IL12 (20 min)
    *** cells: hPHAblasts in BMS
    *** source: 9454765-Fig-3
*** Jnk1--
  *** Jnk1[Ab]IP IVKA(Atf2)[32P-ATP] is unchanged irt IL2 (15 min)
    *** cells: NK33 in BMS
    *** source: 10961885-Fig-2e
  *** Jnk1[Ab]IP IVKA(Atf2)[32P-ATP] is unchanged irt IL12 (15 min)
    *** cells: NK33 in BMS
    *** source: 10961885-Fig-2e
  *** xJnk1[tAb]IP IVKA(Atf2)[32P-ATP] is unchanged irt IL12 (times)
    *** cells: NIH3T3<xIL12Rb1><xIL12Rb1><xJnk1> in BMS
    *** times: 0 30 45 min
    *** source: 10961885-Fig-3b
  *** Jnks[Ab]IP IVKA(Jun)[32P-ATP] is unchanged irt IL12 (times)
    *** cells: 2D6 in BMS "IL12-deprived"
    *** times: 0 5 10 20 min
    *** source: 11801649-Fig-6c
  *** Jnks[phosAb] phos(TPY)[phosAb] is unchanged irt IL12 (15 min)
    *** cells: hPBTCs<Itgb2~neg><Cd8~pos><Cd56~neg><Cd4~neg><Cd20~neg> in BMS
    *** unaffected by: IL2 [cotreatment]
    *** source: 10201984-Fig-2a
*** Jun--
*** Lck--
*** Mkk36s--
  *** Mkk36s[phosAb] phos(sitenr)[phosAb] is increased irt IL12 (tnr)
    *** cells: mSpTh1 in BMS
    *** source: 12213961-Fig-1c
*** Myd88--
*** Myd88--
  *** Myd88-gene mRNA[Northern] is detectable-but unchanged irt IL12 (4 hr)
    *** cells: mSpCs in BMS "activated with anti-Cd3 for 48 hr"
    *** source: 11120802-Fig-4a
  *** Myd88-gene mRNA[Northern] is increased irt IL12 (times)
    *** cells: hPBTCs in BMS "activated"
    *** times: 0 1 2+ 3+ 6+ hr
    *** source: 10925275-Fig-1
  *** Myd88-gene mRNA[Northern] is increased irt IL12 (times)
    *** cells: NK92 in BMS
    *** times: 0+ 1+ 3++ 6++ 12+ hr
    *** source: 10925275-Fig-4
  *** Myd88-gene mRNA[Northern] is unchanged irt IL12 (3 hr)
    *** cells: hNKCs in BMS "resting"
    *** source: 10925275-Fig-3
*** Nfkb1--
*** Nos2a--
  *** Nos2a-gene mRNA[RTPCR] is increased irt IL12 (24 hr)
    *** cells: mPECs in BMS
    *** enhanced by: IL18 [cotreatment]
    *** source: 11207258-Fig-3a
*** P38a--
*** P38s--
*** Pias2--
  *** Pias2[Ab] snaggedby[WB] oligo[agarose] is increased irt IL12 (tnr)
    *** cells: 3F6 in BMS "nuclear-extracts"
    *** source: 12716907-Fig-3b
*** Prf1--
  *** Proliferation[MTT] is increased irt IL12 (tnr)
    *** cells: BAF3<xIL12Rb1><xIL12Rb2> in BMS
    *** source: 11114383-Fig-7d
*** Rab4--
  *** Rab4?-gene mRNA[RTPCR] is unchanged irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 1+ 2+ 3+ 4+ 5+ 6+ hr
    *** source: 16763563-Fig-2d
  *** Rab4s[Ab] prot-exp[WB] is unchanged irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 2+ 4+ 6+ hr
    *** comment: cells were incubated for 3 hr in BMS after stimulus
    *** source: 16763563-Fig-2b
*** Rab5a--
  *** Rab5a-gene mRNA[RTPCR] is unchanged irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 1+ 2+ 3+ 4+ 5+ 6+ hr
    *** source: 16763563-Fig-2d
  *** Rab5b-gene mRNA[RTPCR] is unchanged irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 1+ 2+ 3+ 4+ 5+ 6+ hr
    *** source: 16763563-Fig-2d
  *** Rab5c-gene mRNA[RTPCR] is unchanged irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 1+ 2+ 3+ 4+ 5+ 6+ hr
    *** source: 16763563-Fig-2d
  *** Rab5s[Ab] prot-exp[WB] is unchanged irt IL12 (6 hr)
    *** cells: J774E in BMLS
    *** comment: cells were incubated for 3 hr in BMS after stimulus
    *** source: 16763563-Fig-1b
  *** Rab5s[Ab] prot-exp[WB] is unchanged irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 2+ 4+ 6+ hr
    *** comment: cells were incubated for 3 hr in BMS after stimulus
    *** source: 16763563-Fig-2b
*** Rab6--
*** Rab6--
  *** Rab6?-gene mRNA[RTPCR] is unchanged irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 1+ 2+ 3+ 4+ 5+ 6+ hr
    *** source: 16763563-Fig-2d
  *** Rab6s[Ab] prot-exp[WB] is unchanged irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 2+ 4+ 6+ hr
    *** comment: cells were incubated for 3 hr in BMS after stimulus
    *** source: 16763563-Fig-2b
  *** Rab7?-gene mRNA[RTPCR] is increased irt IL12 (6 hr)
    *** cells: J774E in BMLS
    *** unaffected by: Genistein [pretreatment]
    *** unaffected by: Wortmannin [pretreatment]
    *** unaffected by: LY294002 [pretreatment]
    *** unaffected by: PD98059 [pretreatment]
    *** unaffected by: U0126 [pretreatment]
    *** inhibited by: SB203580 [pretreatment]
    *** unaffected by: SP600125 [pretreatment]
    *** source: 16763563-Fig-3a
  *** Rab7?-gene mRNA[RTPCR] is increased irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 1+ 2+ 3++ 4++ 5++ 6++ hr
    *** source: 16763563-Fig-2d
  *** Rab7?-gene promo-reporter[Luc] is increased irt IL12 (8 hr)
    *** cells: J774E in BMLS
    *** source: 16763563-Fig-4a
  *** Rab7?-gene promo-reporter[Luc] is increased irt IL12 (8 hr)
    *** cells: J774E in BMLS
    *** unaffected by: PD98059 [pretreatment]
    *** inhibited by: SB203580 [pretreatment]
    *** source: 16763563-Fig-4a
  *** Rab7?-gene promo-reporter[Luc] is unchanged irt IL12 (8 hr)
    *** cells: J774E in BMLS
    *** source: 16763563-Fig-4a
  *** Rab7s[Ab] prot-exp[WB] is increased irt IL12 (6 hr)
    *** cells: J774E in BMLS
    *** comment: cells were incubated for 3 hr in BMS after stimulus
    *** source: 16763563-Fig-1b
  *** Rab7s[Ab] prot-exp[WB] is increased irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 2++ 4+++ 6+++ hr
    *** comment: cells were incubated for 3 hr in BMS after stimulus
    *** source: 16763563-Fig-2b
*** Rab11--
  *** Rab11s[Ab] prot-exp[WB] is unchanged irt IL12 (times)
    *** cells: J774E in BMLS
    *** times: 0+ 2+ 4+ 6+ hr
    *** comment: cells were incubated for 3 hr in BMS after stimulus
    *** source: 16763563-Fig-2b
*** Rel--
  *** Rel[Ab] oligo-binding[EMSA] is unchanged irt IL12 (15 min)
    *** cells: mSpDCs in BMS "nuclear-extracts"
    *** source: 9768751-Fig-6a
*** Rela--
  *** Rela[Ab] oligo-binding[EMSA] is unchanged irt IL12 (15 min)
    *** cells: mSpDCs in BMS "nuclear-extracts"
    *** source: 9768751-Fig-6a
*** Relb--
  *** Relb[Ab] oligo-binding[EMSA] is unchanged irt IL12 (15 min)
    *** cells: mSpDCs in BMS "nuclear-extracts"
    *** source: 9768751-Fig-6a
*** Runx3--
  *** Runx3-gene mRNA[RTPCR] is decreased irt IL12 (times)
    *** cells: mSpCD4TCs in BMS "pretreated with anti-Cd3 + anti-Cd28 + anti-IL4 (48 hr)"
    *** times: 0+ 24 48 72+ 96+ 120++ 144++ hr
    *** source: 19409816-Fig-5e
*** Shc1--
  *** Shc1[Ab]IP Yphos[pYAb] is increased irt IL2 (15 min)
    *** cells: hPBTCs in BMS
    *** source: 10961885-Fig-2a
  *** Shc1[Ab]IP Yphos[pYAb] is unchanged irt IL12 (5 min)
    *** cells: NK33 in BMLS
    *** source: 10849428-Fig-3c
  *** Shc1[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: hPBTCs in BMS
    *** source: 10961885-Fig-2a
*** Shp2--
  *** Shp2[Ab]IP Yphos[pYAb] is unchanged irt IL12 (5 min)
    *** cells: hPBTCs in BMLS
    *** source: 9973481-Fig-1a
*** Stat1--
  *** Stat1[Ab] oligo-binding[EMSA] is unchanged irt IL12 (15 min)
    *** cells: KIT225 in BMS "nuclear-extracts"
    *** source: 12716907-Fig-3a
  *** Stat1[Ab] oligo-binding[EMSA] is unchanged irt IL12 (tnr)
    *** cells: 3F6 in BMS
    *** source: 7722452-Fig-3a
  *** Stat1[Ab]IP Yphos[pYAb] is detectable-but unchanged irt IL12 (tnr)
    *** cells: 3F6 in BMS
    *** source: 7722452-Fig-2b
  *** Stat1[Ab]IP Yphos[pYAb] is unchanged irt IL12 (10 min)
    *** cells: hPHAblasts<Cd3e~neg> in BMS
    *** source: 7638186-Fig-2a
  *** Stat1[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: hPHAblasts in BMS
    *** source: 7568001-Fig-2d
  *** Stat1[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: KIT225 in BMLS "IL2-deprived"
    *** source: 7760829-Fig-4a
  *** Stat1[phosAb] phos(Y701)[phosAb] is increased irt IL12 (20 min)
    *** cells: hPHAblasts in BMS
    *** comment: bkg is enhanced when Ifng was added to PHA during blasting
    *** source: 9454765-Fig-1a
  *** Stat1[phosAb] phos(Y701)[phosAb] is increased irt IL12 (20 min)
    *** cells: hPHAblasts in BMS
    *** comment: response inhibited when IL4 was added to PHA during blasting
    *** source: 9454765-Fig-1b
  *** Stat1[phosAb] phos(Y701)[phosAb] is increased irt IL12 (20 min)
    *** cells: hPHAblasts in BMS
    *** source: 9454765-Fig-6a
  *** Stat1[phosAb] phos(Y701)[phosAb] is unchanged irt IL12 (15 min)
    *** cells: hPBTCs<Itgb2~pos><Cd8~pos><Cd56~neg><Cd4~neg><Cd20~neg> in BMS
    *** unaffected by: IL2 [cotreatment]
    *** source: 10201984-Fig-4a
*** Stat2
  *** Stat2[Ab] oligo-binding[EMSA] is unchanged irt IL12 (tnr)
    *** cells: 3F6 in BMS
    *** source: 7722452-Fig-3a
  *** Stat2[Ab]IP Yphos[pYAb] is unchanged irt IL12 (10 min)
    *** cells: hPHAblasts<Cd3e~neg> in BMS
    *** source: 7638186-Fig-2a
  *** Stat2[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: hPHAblasts in BMS
    *** source: 7568001-Fig-2d
  *** Stat2[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: KIT225 in BMLS "IL2-deprived"
    *** source: 7760829-Fig-4a
*** Stat3--
  *** Stat3[Ab] boundto(Ifng-gene)[ChIP] is detectable-but unchanged irt IL12 (1 hr)
    *** cells: hPBTCs in BMS "preactivated with Cd3/Cd28"
    *** unaffected by: CsA [pretreatment]
    *** bkg inhibited by: Rapamycin [pretreatment]
    *** source: 15522880-Fig-3a
  *** Stat3[Ab] copptby[WB] Mtor[Ab] is increased irt IL12 (1 hr)
    *** cells: hPBTCs in BMS "preactivated with Cd3/Cd28"
    *** partially inhibited by: Rapamycin [cotreatment]
    *** source: 15522880-Fig-5
  *** Stat3[Ab] copptby[WB] Stat4[Ab] is increased irt IL12 (1 hr)
    *** cells: hPBTCs in BMS "preactivated with Cd3/Cd28" "nuclear-extracts"
    *** comment: coppt Stat3 is phosed on Y705 and S727 [phosAb]
    *** unaffected by: CsA [pretreatment]
    *** unaffected by: Rapamycin [pretreatment]
    *** source: 15522880-Fig-4a
  *** Stat3[Ab] infraction(nuclear)[WB] is unchanged irt IL12 (1 hr)
    *** cells: hPBTCs in BMS "preactivated with Cd3/Cd28"
    *** unaffected by: CsA [pretreatment]
    *** unaffected by: Rapamycin [pretreatment]
    *** source: 15522880-Fig-4b
  *** Stat3[Ab] oligo-binding[EMSA] is increased irt IL12 (tnr)
    *** cells: 3F6 in BMS
    *** source: 7722452-Fig-3a
  *** Stat3[Ab] oligo-binding[EMSA] is unchanged irt IL12 (15 min)
    *** cells: KIT225 in BMS "nuclear-extracts"
    *** source: 12716907-Fig-3a
  *** Stat3[Ab] oligo-binding[EMSA] is unchanged irt IL12 (20 min)
    *** cells: NKL in BMS "IL2-deprived"
    *** source: 12372421-Fig-4a
  *** Stat3[Ab]IP Yphos[pYAb] is increased irt IL12 (tnr)
    *** cells: 3F6 in BMS
    *** source: 7722452-Fig-2a
  *** Stat3[Ab]IP Yphos[pYAb] is increased irt IL12 (tnr)
    *** cells: 3F6 in BMS
    *** source: 7722452-Fig-2b
  *** Stat3[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: KIT225 in BMLS "IL2-deprived"
    *** source: 7760829-Fig-4a
  *** Stat3[phosAb] phos(S727)[phosAb] is increased irt IL12 (1 hr)
    *** cells: hPBTCs in BMS "preactivated with Cd3/Cd28"
    *** partially reqs: Mtor [RNAi]
    *** source: 15522880-Fig-6a
  *** Stat3[phosAb] phos(S727)[phosAb] is unchanged irt IL12 (1 hr)
    *** cells: hPBTCs in BMS "preactivated with Cd3/Cd28" "nuclear-extracts"
    *** unaffected by: CsA [pretreatment]
    *** unaffected by: Rapamycin [pretreatment]
    *** source: 15522880-Fig-4b
  *** Stat3[phosAb] phos(Y701)[phosAb] is increased irt IL12 (15 min)
    *** cells: hPBTCs<Itgb2~pos><Cd8~pos><Cd56~neg><Cd4~neg><Cd20~neg> in BMS
    *** unaffected by: IL2 [cotreatment]
    *** source: 10201984-Fig-4b
  *** Stat3[phosAb] phos(Y705)[phosAb] is unchanged irt IL12 (1 hr)
    *** cells: hPBTCs in BMS "preactivated with Cd3/Cd28" "nuclear-extracts"
    *** unaffected by: CsA [pretreatment]
    *** unaffected by: Rapamycin [pretreatment]
    *** source: 15522880-Fig-4b
*** Stat4--
  *** Stat4[Ab] copptby[WB] Jun[Ab] is detectable-but unchanged irt IL12 (2 hr)
    *** cells: mSpCs in BMS "pretreated with anti-Cd3 for 72 hr"
    *** comment: coppt Stat4 phos(sitenr)[phosAb] is increased irt IL12
    *** source: 14660657-Fig-5b
  *** Stat4[Ab] copptby[WB] Pias2[Ab] is increased irt IL12 (tnr)
    *** cells: KIT225 in BMS
    *** source: 12716907-Fig-1d
  *** Stat4[Ab] infraction(nuclear)[WB] is unchanged irt IL12 (1 hr)
    *** cells: hPBTCs in BMS "preactivated with Cd3/Cd28"
    *** unaffected by: CsA [pretreatment]
    *** unaffected by: Rapamycin [pretreatment]
    *** source: 15522880-Fig-4b
  *** Stat4[Ab]IP Yphos[pYAb] is increased irt IL12 (20 min)
    *** cells: hPHAblasts in BMS
    *** source: 11114383-Fig-7d
*** Stat5a--
  *** Stat5a[Ab]IP Yphos[pYAb] is increased irt IL12 (20 min)
    *** cells: hPHAblasts in BMS
    *** comment: bkg is enhanced when Ifng was added to PHA during blasting
    *** source: 9454765-Fig-2b
*** Stat5s--
  *** Stat5s[Ab] boundto(IL2Ra-gene)[ChIP] is unchanged irt IL12 (4 hr)
    *** cells: mSpCs in BMS "pretreated with anti-Cd3 for 72 hr"
    *** source: 14660657-Fig-3
  *** Stat5s[Ab] oligo-binding[EMSA] is increased irt IL12 (20 min)
    *** cells: hPHAblasts in BMS "nuclear-extracts"
    *** comment: response inhibited when IL4 was added to PHA during blasting
    *** source: 9454765-Fig-2c
  *** Stat5s[Ab] oligo-binding[EMSA] is unchanged irt IL12 (20 min)
    *** cells: NKL in BMS "IL2-deprived"
    *** source: 12372421-Fig-4a
  *** Stat5s[Ab] snaggedby[WB] oligo[biotin] is unchanged irt IL12 (1 hr)
    *** cells: mSpCs in BMS "pretreated with anti-Cd3 for 72 hr" "cotreated with anti-IL2"
    *** source: 14660657-Fig-2b
  *** Stat5s[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: hPHAblasts in BMS
    *** source: 7568001-Fig-2d
  *** Stat5s[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: KIT225 in BMLS "IL2-deprived"
    *** source: 7760829-Fig-4a
  *** Stat5s[phosAb] phos(DGYV)[phosAb] is unchanged irt IL12 (15 min)
    *** cells: hPBTCs<Itgb2~pos><Cd8~pos><Cd56~neg><Cd4~neg><Cd20~neg> in BMS
    *** source: 10201984-Fig-4a
  *** Stat5s[phosAb] phos(Y694)[phosAb] is increased irt IL12 (20 min)
    *** cells: hPHAblasts in BMS
    *** comment: bkg is enhanced when Ifng was added to PHA during blasting
    *** source: 9454765-Fig-2a
  *** Stat5s[phosAb] phos(Y694)[phosAb] is increased irt IL12 (20 min)
    *** cells: hPHAblasts in BMS
    *** comment: response inhibited when IL4 was added to PHA during blasting
    *** source: 9454765-Fig-2b
  *** Stat5s[phosAb] phos(Y694)[phosAb] is increased irt IL12 (20 min)
    *** cells: hPHAblasts in BMS "blasted in the presence of Ifng"
    *** source: 9454765-Fig-6a
  *** Stat5s[phosAb] phos(Y694)[phosAb] is unchanged irt IL12 (20 min)
    *** cells: hPHAblasts in BMS
    *** source: 9454765-Fig-6a
*** Stat6--
  *** Stat6[Ab] oligo-binding[EMSA] is decreased irt IL12 (1 hr)
    *** cells: hTh2 in BMS
    *** source: 9531298-Fig-4a
  *** Stat6[Ab] oligo-binding[EMSA] is increased irt IL12 (1 hr)
    *** cells: hTh1 in BMS
    *** enhanced by: IL4 [cotreatment]
    *** source: 9531298-Fig-4a
  *** Stat6[Ab]IP Yphos[pYAb] is unchanged irt IL12 (15 min)
    *** cells: KIT225 in BMLS "IL2-deprived"
    *** source: 7760829-Fig-4a
*** StatRE--
  *** StatRE-reporter[Luc] is increased irt IL12 (6 hr)
    *** cells: NIH3T3<xIL12Rb1><xIL12Rb1><xStat4> in BMS
    *** inhibited by: SB202190 [pretreatment]
    *** source: 10961885-Fig-5a
  *** StatRE-reporter[Luc] is increased irt IL12 (8 hr)
    *** cells: JURKAT<Pten~null><xStat4> in BMS
    *** bkg inhibited by: xStat4(S271A) [substitution]
    *** unaffected by: xStat4(S723A) [substitution]
    *** bkg inhibited by: xStat4(Y693F) [substitution]
    *** source: 10961885-Fig-1c
  *** StatRE-reporter[Luc] is increased irt IL12 (8 hr)
    *** cells: NIH3T3<xIL12Rb1><xIL12Rb1><xStat4> in BMS
    *** enhanced by: xMkk6 [addition]
    *** enhanced by: xMkk6 + xP38a [addition]
    *** partially inhibited by: xMek?(mnr)"CA" + xErk2 [addition]
    *** unaffected by: xMekk1 + xJnk1 [addition]
    *** unaffected by: xMek5(mnr)"CA" + xErk5 [addition]
    *** source: 10961885-Fig-4a
  *** StatRE-reporter[Luc] is increased irt IL12 (8 hr)
    *** cells: NIH3T3<xIL12Rb1><xIL12Rb1><xStat4> in BMS
    *** enhanced by: xMkk6 + xP38a [addition]
    *** unaffected by: xMkk6 + xP38g [addition]
    *** source: 10961885-Fig-4b
  *** StatRE-reporter[Luc] is increased irt IL12 (8 hr)
    *** cells: NIH3T3<xIL12Rb1><xIL12Rb1><xStat4> in BMS
    *** partially inhibited by: xMkk6(mnr)"DN" [addition]
    *** unaffected by: xMek?(mnr)"DN" [addition]
    *** source: 10961885-Fig-5b
  *** StatRE-reporter[Luc] is increased irt IL12 (8 hr)
    *** cells: NIH3T3<xIL12Rb1><xIL12Rb1><xStat4> in BMS
    *** partially inhibited by: xStat4(S271A) [substitution]
    *** unaffected by: xStat4(S723A) [substitution]
    *** inhibited by: xStat4(Y693F) [substitution]
    *** source: 10961885-Fig-3d
*** Tbet--
  *** Tbet-gene mRNA[Northern] is increased irt IL12 (72 hr)
    *** cells: mLNCs<Cd4~pos> in BMS "cotreated with anti-Cd3/anti-Cd28 for 72 hr"
    *** unaffected by: IL18 [cotreatment]
    *** source: 11786664-Fig-3a
  *** Tbet-gene mRNA[Northern] is increased irt IL12 (72 hr)
    *** cells: mLNCs<Cd8~pos> in BMS "cotreated with anti-Cd3/anti-Cd28 for 72 hr"
    *** unaffected by: IL18 [cotreatment]
    *** source: 11786664-Fig-3a
  *** Tbet-gene mRNA[RTPCR] is increased irt IL12 (times)
    *** cells: mSpCD4TCs in BMS "pretreated with anti-Cd3 + anti-Cd28 + anti-IL4 (48 hr)"
    *** times: 0 1++ 2+ 3+ 4++ 5++ 6++ days
    *** comment: reqs IfngR1 [KO] for increase at day 1 only
    *** source: 19409816-Fig-1a
  *** Tbet-gene mRNA[RTPCR] is increased irt IL12 (times)
    *** cells: mSpCD4TCs in BMS "pretreated with anti-Cd3 + anti-Cd28 + anti-IL4 (48 hr)"
    *** times: 0 1++ 2+ 3+ 4++ 5++ days
    *** comment: addition of CsAe on day 1 causes a faster increase
    *** source: 19409816-Fig-4d
  *** Tbet-gene mRNA[RTPCR] is increased irt IL12 (times)
    *** cells: mSpCD4TCs in BMS "pretreated with anti-Cd3 + anti-Cd28 + anti-IL4 (48 hr)"
    *** times: 0 1++ 2+ 3+ 4++ 5++ days
    *** comment: reqs IfngR1 [KO] for increase at day 1 only
    *** source: 19409816-Fig-4a
  *** Tbet-gene mRNA[RTPCR] is increased irt IL12 (times)
    *** cells: mSpCD4TCs in BMS "pretreated with anti-Cd3 + anti-Cd28 + anti-IL4 (48 hr)"
    *** times: 0 5+ 20+ 28+++ 48++ 72+ 96++ 120++ 144++ hr
    *** comment: inhibited by anti-Ifng at 5-72 hr
    *** source: 19409816-Fig-5a
*** TcRa--
  *** TcRa-gene mRNA[Northern] is detectable-but unchanged irt IL12 (4 hr)
    *** cells: mSpCs in BMS "activated with anti-Cd3 for 48 hr"
    *** comment: cells from Stat4-null mice equivalent levels of TcRa-gene mRNA
    *** source: 11120802-Fig-1a
*** TcRb--
  *** TcRb-gene mRNA[Northern] is unchanged irt IL12 (3 hr)
    *** cells: hNKCs in BMS
    *** source: 8103068-Fig-3a
*** DNA-synthesis--
  *** DNA-synthesis[3H-Thymidine] is increased irt IL12 (2 days)
    *** cells: mLNTCs in BMS
    *** repressed by: Socs1 [KO]
    *** source: 12221108-Fig-1a
  *** DNA-synthesis[3H-Thymidine] is increased irt IL12 (3 days)
    *** cells: mLNTCs in BMS
    *** repressed by: Socs1 [KO]
    *** source: 12221108-Fig-1a
  *** DNA-synthesis[3H-Thymidine] is increased irt IL12 (5 days)
    *** cells: hPHAblasts in BMS "cultured with anti-Cd3 + anti-Cd28"
    *** partially inhibited by: anti-IL12Rb1 [cotreatment]
    *** inhibited by: anti-IL12 [cotreatment]
    *** inhibited by: anti-IL12a [cotreatment]
    *** source: 11114383-Fig-6b
  *** DNA-synthesis[3H-Thymidine] is increased irt IL12 (24 hr)
    *** cells: mSpCs<Stat4~null><xStat4> in BMS
    *** reqs: xStat4 [omission]
    *** unaffected by: xStat4(Y693F)[phosAb] [substitution]
    *** inhibited by: xStat4(S721A)[phosAb] [substitution]
    *** source: 12213961-Fig-2c
  *** DNA-synthesis[3H-Thymidine] is increased irt IL12 (48 hr)
    *** cells: BAF3<xIL12Rb1><xIL12Rb2> in BMS
    *** reqs: xIL12Rb2 [omission]
    *** comment: a higher concentration of IL12 is required in the absence of xILRb1
    *** source: 8943050-Fig-5
  *** DNA-synthesis[3H-Thymidine] is increased irt IL12 (48 hr)
    *** cells: mSpCs in BMS "activated with anti-Cd3 for 48 hr"
    *** enhanced by: IL18 [cotreatment]
    *** source: 11120802-Fig-3c
  *** DNA-synthesis[3H-Thymidine] is increased irt IL12 (tnr)
    *** cells: 2D6 in BMS
    *** unaffected by: xSphk2(G212D)"DN" [addition]
    *** unaffected by: xSphk2 [addition] 
    *** source: 12874225-Fig-5
  *** DNA-synthesis[3H-Thymidine] is increased irt IL12 (tnr)
    *** cells: mSpTCs in BMS "activated with anti-Cd3/anti-Cd28"
    *** unaffected by: xSphk2(G212D)"DN" [addition]
    *** source: 12874225-Fig-6
*** Traf6--
  *** Traf6-gene mRNA[Northern] is detectable-but unchanged irt IL12 (4 hr)
    *** cells: mSpCs in BMS "activated with anti-Cd3 for 48 hr"
    *** source: 11120802-Fig-4a
*** Tyk2--
